Literature DB >> 3612657

Drug abuse and human immunodeficiency virus infection in Scotland.

R P Brettle.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3612657      PMCID： PMC1290806          DOI： 10.1177/014107688708000505

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  23 in total

1.  Prevalence of antibody to lymphadenopathy-associated virus among drug-detoxification patients in New York.

Authors:  T J Spira; D C Des Jarlais; M Marmor; S Yancovitz; S Friedman; J Garber; H Cohen; C Cabradilla; V C Kalyanaraman
Journal:  N Engl J Med       Date:  1984-08-16       Impact factor: 91.245

2.  High frequency of HTLV-III antibodies among heterosexual intravenous drug abusers in the Austrian Tyrol.

Authors:  D Fuchs; H G Blecha; F Deinhardt; M P Dierich; F D Goebel; P Hengster; H Hinterhuber; D Schoenitzer; K Traill; H Wachter
Journal:  Lancet       Date:  1985-06-29       Impact factor: 79.321

3.  HTLV-III antibody among Italian drug addicts.

Authors:  P Ferroni; D Geroldi; C Galli; A R Zanetti; A Cargnel
Journal:  Lancet       Date:  1985-07-06       Impact factor: 79.321

4.  HTLV-III antibody in Swiss and English intravenous drug abusers.

Authors:  P P Mortimer; E M Vandervelde; W J Jesson; M S Pereira; F Burkhardt
Journal:  Lancet       Date:  1985-08-24       Impact factor: 79.321

5.  Antibody to human T-lymphotropic virus type III in wives of hemophiliacs. Evidence for heterosexual transmission.

Authors:  J K Kreiss; L W Kitchen; H E Prince; C K Kasper; M Essex
Journal:  Ann Intern Med       Date:  1985-05       Impact factor: 25.391

6.  Transmission of lymphadenopathy-associated virus/human T lymphotropic virus type III in sexual partners. Seropositivity does not predict infectivity in all cases.

Authors:  H Burger; B Weiser; W S Robinson; J Lifson; E Engleman; C Rouzioux; F Brun-Vézinet; F Barré-Sinoussi; L Montagnier; J C Chermann
Journal:  Am J Med       Date:  1986-07       Impact factor: 4.965

7.  Transmission of human T-cell lymphotropic virus type III (HTLV-III) by artificial insemination by donor.

Authors:  G J Stewart; J P Tyler; A L Cunningham; J A Barr; G L Driscoll; J Gold; B J Lamont
Journal:  Lancet       Date:  1985-09-14       Impact factor: 79.321

8.  Human T-lymphotropic virus type III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII.

Authors:  C A Ludlam; J Tucker; C M Steel; R S Tedder; R Cheingsong-Popov; R A Weiss; D B McClelland; I Philp; R J Prescott
Journal:  Lancet       Date:  1985-08-03       Impact factor: 79.321

9.  IgM and IgG antibodies to human T cell lymphotropic retrovirus (HTLV-III) in lymphadenopathy syndrome and subjects at risk for AIDS in Italy.

Authors:  F Aiuti; P Rossi; M C Sirianni; M Carbonari; M Popovic; M G Sarngadharan; L Contu; M Moroni; S Romagnani; R C Gallo
Journal:  Br Med J (Clin Res Ed)       Date:  1985-07-20

10.  Mothers of infants with the acquired immunodeficiency syndrome. Evidence for both symptomatic and asymptomatic carriers.

Authors:  G B Scott; M A Fischl; N Klimas; M A Fletcher; G M Dickinson; R S Levine; W P Parks
Journal:  JAMA       Date:  1985-01-18       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.